Health Payer Intelligence September 11, 2019
– Among publicly insured patients with the potentially chronic condition hepatocellular carcinoma (HCC), 35 percent had a longer wait time for a liver transplant, possibly indicating poor care coordination according to researchers from the University of California, San Francisco (UCSF).
Delays in finishing the pre-transplant evaluations and in securing upgrades on the Model for End-Stage Liver Disease (MELD) are the predominant causes for these delays. The researchers concluded that better care coordination and improved delivery would speed up the process for publicly insured patients.
“Public insurance should be recognized as a risk factor associated with waitlist dropout, and necessary steps should be implemented to mitigate the increased risk of dropout among these patients,” Neil Mehta, MD, UCSF...
Today's Sponsors
Today's Sponsor